^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    UCSF 500 Cancer Gene Panel Test

    Company:
    University of California
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    The UCSF 500 Cancer Gene Test uses capture-based next-generation sequencing to target and analyze the coding regions (exons) of 529 cancer genes, as well as select introns of 47 genes. This test can be ordered on solid tumors, hematopoietic malignancies, or lesional tissue specimens.
    Cancer:
    Solid Tumor
    Gene:
    AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), AXIN1 (Axin 1), CCND3 (Cyclin D3)
    See More ...
    Method:
    Next-Generation Sequencing